Binding‐Site Purification of Actives (B‐SPA) Enables Efficient Large‐Scale Progression of Fragment Hits by Combining Multi‐Step Array Synthesis With HT Crystallography
Angewandte Chemie International Edition · 11.04.2025 · 64 (16)
DOI: 10.1002/anie.202424373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 18.03.2025. Verfasst von Harold Grosjean und 15 weiteren Autor:innen. Beteiligte Einrichtung: Diamond Light Source Ltd, Harwell Science and Innovation Campus, OX11 0QX, Didcot, UK. Hauptthemen laut MEDLINE: Binding Sites, Crystallography, X-Ray. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Fragment approaches are long‐established in target‐based ligand discovery, yet their full transformative potential lies dormant because progressing the initial weakly binding hits to potency remains a formidable challenge. The only credible progression paradigm involves multiple cycles of costly conventional design‐make‐test‐analyse medicinal chemistry. We propose an alternative approach to fragment elaboration, namely performing large numbers of parallel and diverse automated multiple step reactions, and evaluating the binding of the crude reaction products by high‐throughput protein X‐ray crystallography. We show it is effective and low‐cost to perform, in parallel, large numbers of non‐uniform multi‐step reactions, because, even without compound purification, crystallography provides a high‐quality readout of binding. This can detect low‐level binding of weakly active compounds, which the target binding site extracts directly from crude reaction mixtures. In this proof‐of‐concept study, we have expanded a fragment hit, from a crystal‐based screen of the second bromodomain of pleckstrin homology domain‐interacting protein (PHIP(2)), using array synthesis on low‐cost robotics. We were able to implement 6 independent multi‐step reaction routes of up to 5 steps, attempting the synthesis of 1876 diverse expansions, designs entirely driven by synthetic tractability. The expected product was present in 1108 (59%) crude reaction mixtures, detected by liquid chromatography mass spectrometry (LCMS). 22 individual products were resolved in the crystal structures of crude reaction mixtures added to crystals, providing an initial structure activity relationship map. 19 of these showed binding pose stability, while, through binding instability in the remaining 3 products, we could resolve a stereochemical preference for mixtures containing racemic compounds. One compound showed biochemical potency (IC 50 =34 μM) and affinity (K d =50 μM) after resynthesis. This approach therefore lends itself to routine fragment progression, if coupled with algorithmically guided compound and reaction design and new formalisms for data analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diamond Light Source Ltd, Harwell Science and Innovation Campus, OX11 0QX, Didcot, UK.
- Structural Bioinformatics and Computational Biochemistry, Departement of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK.
- Research Complex at Harwell, Harwell Science and Innovation Campus, OX11 0FA, Didcot, UK.
- Department of Chemistry, School of Life Sciences, University of Sussex, Falmer, BN1 9QJ, UK.
- Centre for Medicines Discovery, University of Oxford, Old Road Campus, Roosevelt Drive, OX3 7DQ, Headington, UK.
- Structural Genomics Consortium, University of Oxford, Old Road Campus, Roosevelt Drive, OX3 7DQ, Headington, UK.
ORCID-Profile: Harold Grosjean, Anthony Aimon, Storm Hassell-Hart, Warren Thompson, Lizbé Koekemoer, James Bennett, Anthony Bradley, Cameron Anderson, William J Bradshaw, Edward A FitzGerald, Tobias Krojer, Oleg Fedorov, Philip C Biggin, John Spencer, Frank von Delft
Förderung
- Engineering and Physical Sciences Research Council
Zitieren
APA
Grosjean, H., Aimon, A., Hassell-Hart, S., Thompson, W., Koekemoer, L., Bennett, J., Bradley, A., Anderson, C., Wild, C., Bradshaw, W. J., FitzGerald, E. A., Krojer, T., Fedorov, O., Biggin, P. C., Spencer, J., & von Delft, F. (2025). Binding‐Site Purification of Actives (B‐SPA) Enables Efficient Large‐Scale Progression of Fragment Hits by Combining Multi‐Step Array Synthesis With HT Crystallography. Angewandte Chemie International Edition, 64(16). https://doi.org/10.1002/anie.202424373
Vancouver
Grosjean H, Aimon A, Hassell-Hart S, Thompson W, Koekemoer L, Bennett J, et al. Binding‐Site Purification of Actives (B‐SPA) Enables Efficient Large‐Scale Progression of Fragment Hits by Combining Multi‐Step Array Synthesis With HT Crystallography. Angewandte Chemie International Edition. 2025;64(16). doi:10.1002/anie.202424373
BibTeX
@article{Grosjean2025,
author = {Grosjean, Harold and Aimon, Anthony and Hassell-Hart, Storm and Thompson, Warren and Koekemoer, Lizbé and Bennett, James and Bradley, Anthony and Anderson, Cameron and Wild, Conor and Bradshaw, William J and FitzGerald, Edward A and Krojer, Tobias and Fedorov, Oleg and Biggin, Philip C and Spencer, John and von Delft, Frank},
title = {Binding‐Site Purification of Actives (B‐SPA) Enables Efficient Large‐Scale Progression of Fragment Hits by Combining Multi‐Step Array Synthesis With HT Crystallography},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {16},
doi = {10.1002/anie.202424373}
}
EUVIMED